Want to join the conversation?
$CME's overall futures and options contract volume for 1Q16 increased by 13% from last year. This was largely due to rise in equity and interest rate contract volume, as global market concerns and considerable uncertainty regarding Federal Reserve's interest rate policy have resulted in increased volatility in equity and interest rate markets.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.